180 related articles for article (PubMed ID: 8720715)
1. Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients.
Zavazava N; Nölle B; Duncker G; Jenisch S; Westphal E; Eckstein V; Müller-Ruchholtz W
Graefes Arch Clin Exp Ophthalmol; 1996 Mar; 234(3):164-70. PubMed ID: 8720715
[TBL] [Abstract][Full Text] [Related]
2. [HLA typing in high risk keratoplasty].
Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial cells in post mortem HLA typing of corneal donors.
Baumgartner I; Asenbauer TT; Kaminski SL; Grabner G; Mayr WR
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1940-5. PubMed ID: 1582799
[TBL] [Abstract][Full Text] [Related]
4. Post-mortem HLA tissue typing of retinal pigment epithelial cells.
Zavazava N; Westphal E; Duncker G; Nölle B; Müller-Ruchholtz W
Scand J Immunol Suppl; 1992; 11():192-4. PubMed ID: 1514040
[TBL] [Abstract][Full Text] [Related]
5. Expression of MHC class I and II molecules by cadaver retinal pigment epithelium cells: optimization of post-mortem HLA typing.
Zavazava N; Halene M; Westphal E; Nölle B; Duncker G; Eckstein E; Harpprecht J; Müller-Ruchholtz W
Clin Exp Immunol; 1991 Apr; 84(1):163-6. PubMed ID: 1901778
[TBL] [Abstract][Full Text] [Related]
6. [Postmortem serologic and biochemical HLA typing with cultivated retinal pigment epithelium cells].
Nölle B; Halene M; Zavazava N; Westphal E; Duncker G; Müller-Ruchholtz W
Fortschr Ophthalmol; 1991; 88(6):629-32. PubMed ID: 1794780
[TBL] [Abstract][Full Text] [Related]
7. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty.
Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
Dev Ophthalmol; 2003; 36():42-9. PubMed ID: 12494679
[TBL] [Abstract][Full Text] [Related]
8. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
[TBL] [Abstract][Full Text] [Related]
9. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes.
Osawa H; Streilein JW
Cornea; 2005 Apr; 24(3):312-8. PubMed ID: 15778605
[TBL] [Abstract][Full Text] [Related]
10. Preliminary findings in corneal allograft rejection in patients with keratoconus.
Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space.
Zhang X; Bok D
Invest Ophthalmol Vis Sci; 1998 May; 39(6):1021-7. PubMed ID: 9579482
[TBL] [Abstract][Full Text] [Related]
12. HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty.
Reinhard T; Böhringer D; Enczmann J; Kögler G; Wernet P; Böhringer S; Sundmacher R
Acta Ophthalmol Scand; 2004 Feb; 82(1):13-8. PubMed ID: 14738484
[TBL] [Abstract][Full Text] [Related]
13. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
[TBL] [Abstract][Full Text] [Related]
14. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
15. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.
Khaireddin R; Wachtlin J; Hopfenmüller W; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1020-8. PubMed ID: 14673570
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
Wood KJ; Hopley A; Dallman MJ; Morris PJ
Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
19. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
20. The immune privilege of corneal grafts.
Niederkorn JY
J Leukoc Biol; 2003 Aug; 74(2):167-71. PubMed ID: 12885932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
